Pharmaceuticals

As per available reports about 40 journals, 20 Conferences are presently dedicated exclusively to Pharmaceuticals and about 352 articles are being published on the current trends in Pharmaceuticals. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Pharmaceuticals are classified in a variety of other groups as well their source on the origin of pharmacological properties like mode of accomplishment and their pharmacological act or action, route of administration, biological system affected, or restorative effects. Pharmaceuticals in the international trade in pharmaceuticals and intellectual property rights, with developed world nations seeking strong intellectual property rights to protect investments made to develop new drugs, and developing world nations seeking to promote their generic pharmaceuticals industries and their ability to make medicine available to the people.

The International Journal of Research and Development in Pharmacy and Life Sciences is an open access journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Pharmaceutical Regulatory Affairs researches. Pharmaceutical Regulatory Affairs: Open Access is an academic journal that includes a wide range of fields in its discipline such as technological, legal, ethical and market oriented information from across the globe to create a platform for the authors to make their contributions towards the scholarly journals. Pharmaceutical Regulatory Affairs: Open Access is set of norms, standards, and code of conduct governs the pharmaceutical industries across the globe to ensure a safe and secured healthcare system to all.

OMICS International – a pioneering organizing international conferences. OMICS Group officially welcomes the scientific community to attend the 4th International Conference on Pharmaceutical Regulatory Affairs Conference. This International conference is an excellent opportunity for the participants like Regulatory affairs professionals, Quality and manufacturing professionals, Clinical development professionals, Regulatory authorities, Business and marketing professionals in pharmaceutical sector. The scientific sessions of the event is formulated with current regulatory aspects like API (Active Pharmaceutical Ingredients), scheduled drugs, over the counter drugs, subsequent process validation, audit process and inspection, common technical document, NDA (New Drug Application) and ANDA (Abbreviated New Drug Application) providing an up to date and in-depth information on the present scenario with pharma regulatory world.